Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion

NCT02018445 is registered in ClinicalTrials.gov with SeaSpine, Inc. as lead sponsor.

NCT NCT02018445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02018445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion
Lead sponsor
SeaSpine, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2013
Completion date
May 31, 2017
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative changes, spondylosis, stenosis